← All stocks

Natera, Inc.

NTRA Net selling
CIK 0001604821 #586 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$384.36M
$230.55M on a plan · $107.90M straight out of an exercise
Sold at will
$45.90M
21 of 493 sales
Net
−$384.36M
−$45.90M against sales at will

By person

17 insiders · 498 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
$133.06M (96) scheduled
−$133.06M
2,127,394
1.48%
$744.60M
−12.5%
Chapman Steven Leonard
CEO AND PRESIDENT
$93.95M (58) scheduled
−$93.95M
459,452
0.3187%
$160.81M
−17.5%
BOTHA ROELOF
Director
$34.89M (17)
−$34.89M
1,080,783
0.7498%
$378.28M
−17.9%
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
$23.83M (42) scheduled
−$23.83M
170,073
0.1180%
$59.53M
−17.6%
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
$22.88M (64) scheduled
−$22.88M
110,859
0.0769%
$38.80M
−1.4%
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
$22.14M (42) scheduled
−$22.14M
51,637
0.0358%
$18.07M
−28.2%
Sheena Jonathan
Director
$22.13M (133) scheduled
−$22.13M
295,274
0.2048%
$103.35M
−34.9%
ROSENMAN HERM
Director
$15.14M (5)
−$15.14M
5,927
0.0041%
$2.07M
−91.0%
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
$9.35M (18) scheduled
−$9.35M
197,257
0.1368%
$69.04M
+72.1%
Baynes Roy D.
Director
$2.81M (8) scheduled
−$2.81M
20,158
0.0140%
$7.06M
+28.5%
Marcus Gail Boxer
Director
$2.41M (5) scheduled
−$2.41M
7,852
0.0054%
$2.75M
−63.6%
Chapman Rowan E
Director
$1.76M (5) scheduled
−$1.76M
4,663
0.0032%
$1.63M
−41.5%
HEALY JAMES
Director
46,260
0.0321%
$16.19M
+0.9%
Bertagnolli Monica
Director
7,020
0.0049%
$2.46M
Williams Brinkley Ruth
Director
5,475
0.0038%
$1.92M
+84.7%
Rubin Eric H
Director
2,204
0.0015%
$771.42K
Lynch Thomas J. Jr.
Director
1,905
0.0013%
$666.76K
Insider
Date
Role
Action
Shares
Price
Amount
Marcus Gail Boxer
5 Jun 2026
Director
Sold after exercise
116
$218.82
$25.38K
Marcus Gail Boxer
5 Jun 2026
Director
Sold after exercise
3,174
$218.11
$692.28K
Marcus Gail Boxer
5 Jun 2026
Director
Sold after exercise
4,694
$217.30
$1.02M
Marcus Gail Boxer
5 Jun 2026
Director
Sold after exercise
3,016
$216.06
$651.65K
Showing 250 of 498 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 175
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 418
Sales straight out of an exercise 54
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 1,154,206
History held since 7 Sep 2016